The distinct phenomena indicate that IRHOM2 may have a variety of different chemical modifications that synergistically or competitively regulate NASH progression by other unknown factors and molecular mechanisms. This evidence concerns the gene RHBDF2 and metabolic dysfunction-associated steatohepatitis.